• No results found

Determinants of disease course in rheumatoid arthritis Linn-Rasker, S.P.

N/A
N/A
Protected

Academic year: 2021

Share "Determinants of disease course in rheumatoid arthritis Linn-Rasker, S.P."

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Determinants of disease course in rheumatoid

arthritis

(2)

11_9 WT PROEFSCHRIFT 1

(3)

S.P. Linn-Rasker

Determinants of disease course in rheumatoid arthritis. Thesis Leiden University, November 2, 2006

ISBN-10: 90-9021048-2 ISBN-13: 978-90-9021048-3

All rights reserved. No part of this publication maybe reproduced or transmitted in any form or bij any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission from the authors.

Printed by Ridderprint te Ridderkerk

Determinants of disease course

in rheumatoid arthritis

Proefschrift

Ter verkrijging van de graad van Doctor aan de Universiteit Leiden op gezag van de Rector Magnifi cus Dr D.D. Breimer,

hoogleraar in de faculteit der Wiskunde en Natuurwetenschappen en die der Geneeskunde, volgens besluit van het College voor promoties te verdedigen op donderdag 2 november 2006

te klokke 15.00 uur

door

Suzanne Paulowna Linn-Rasker

Geboren te Groningen in 1969

11_9 WT PROEFSCHRIFT 2-3

(4)

Voor Roel, Coen en Gijs

Promotiecommissie

Promotores: Prof. dr. T.W.J. Huizinga Prof. dr. F.C. Breedveld Referent: Prof. dr. J.W.J Bijlsma Overige Leden: Dr. S. le Cessie

Dr. F. W. Dekker

Publication of this thesis was fi nancially supported by Astra Zeneca BV

Sanofi -aventis Netherlands BV Wyeth pharmaceuticals Roche MSD Dutch Arthritis Association Reuma en artrose stichting

11_9 WT PROEFSCHRIFT 4-5

(5)

6 Written by S.P. Linn-Rasker Amersfoort The Netherlands Chapter 1 Introduction Chapter 2

Auto-antibodies to cyclic citrullinated peptides predict progression in rheumatoid arthritis patients with undifferentiated arthritis

Arthritis and Rheumatism volume 50 no 3 March 2004

Chapter 3

Arthritis of the large joints, in particular the knee, at fi rst presentation is predictive of a high level of destruction of the small joints in rheumatoid arthritis.

Submitted, April 2006

Chapter 4

Sustained remission in a cohort of patients with rheumatoid arthritis: association with absence of IgM rheumatoid factor and absence of anti-CCP antibodies.

Advances in Rheumatology 2004 volume 2

Chapter 5

Smoking is only a risk factor for anti-CCP formation in RA patients that carry the HLA-DRB1 shared epitope alleles.

Annals of the Rheumatic Disease July 2005

Chapter 6

Genetic drift as an explanation for the reduced incidence of rheumatoid arthritis

Letter, Arthritis and Rheumatism November 2002

Referenties

GERELATEERDE DOCUMENTEN

In a Swedish cohort of 183 patients with early RA (mean disease duration 11 months), who were followed 6-monthly for at least 5 years, 39 patients (20%) achieved remission

The presence of anti-CCP autoanti- bodies was an important predictor for RA, since within 3 years, 93% of the patients who tested positive for anti-CCP antibodies were classifi ed

Regression analyses in both groups of RA-patients and using the approach of the extremes of the disease courses yielded the total number of swollen joints and particularly

Follow-up data from our early arthritis cohort have demonstrated that from the patients with undifferentiated arthritis 28% progress to polyarthritis fulfi lling the ACR criteria

However given the fact that SE alone is not a risk factor for anti-CCP negative RA (19) , the gene-environment interaction between smoking and SE leading to anti-CCP antibodies

74 75 With respect to the IL-10 locus, this must have led to an increase of IL-10 R3 (which protects against RA) in the general population. This genetic drift may explain the

The fact that so many factors are registered on these patients, facilitates the task of drawing conclusions on clinical remission, the predictive value of anti-CCP antibodies in

Het feit dat zoveel gegevens over deze patiënten gedocumenteerd waren, maakte het mogelijk om conclusies te trekken over klinische remissie, de waarde van anti-CCP antistoffen